Positive Health Online

Vitamin K2 Significantly Reduces Risk Cancer

Recent studies have suggested an anticarcinogenic effect of vitamin K2 on prostate cancer of approx 50%, while no effect was found for K1. In a new study from the researchers from the German Cancer Research Centre confirms and even extents this effect: the potential benefits of vitamin K2 accounts for overall-cancer risk in both men and women, whereas vitamin K1 shows no effect.
 
The findings, based on data from the 24,340 men and women taking part in the prospective EPIC Heidelberg cohort, are published in this month's issue of  the American Journal of Clinical Nutrition.* All 24,340 participants (aged 35-64 y) were free of cancer at enrolment and followed up for cancer incidence and mortality. Dietary vitamin K intake was estimated from food-frequency questionnaires. During a 10 year follow-up, 1755 incident cancer cases occurred, of which 458 were fatal. Cancer risk reduction with increasing intake of vitamin K2, mainly the long chain menaquinones such as NattoPharma's MenaQ7 was recorded.
 
In general, the researchers found, the one quarter with the highest intakes of vitamin K2 were 28% less likely to have died of any one of the 22 different cancers than the one-quarter of men and women with the lowest intakes of the vitamin. Subjects in the highest quartile of vitamin K2 had a 62% reduced risk of lung cancer and lung cancer mortality. For prostate cancer this figure was 42% reduced risk.
 
"It is at least remarkable that cancer-prevention was found to occur at similar intakes of vitamin K2 as the previously observed protection against cardiovascular disease and mortality. Both for cancer protection and cardiovascular disease prevention a nutritional dose of 45 micrograms per day was found to show a significant effect, although probably more profound effects may even be expected from higher doses" says Cees Vermeer, PhD, Associate Professor of Biochemistry VitaK BV,  Maastricht University.
 
The study has been appreciated by Leon Schurgers PhD, from the Cardiovascular Research Institute CARIM at the University of Maastricht and Vice President of NattoPharma, Oslo, Norway. "The anti-carcinogenic effect of K2 vitamins has been suggested in several previous papers. The study of Nimptsch and colleagues confirms and adds significant evidence that especially vitamin K2 have anti-carcinogenic properties. The beauty of this paper is that the effect is found at nutritional doses of vitamin K2" says Schurgers.
 

Source

American Journal of Clinical Nutrition, online March 24, 2010.
Reuters Health, March 31. 2010.
*Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).[1,2,3]
1. From the Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany (KN SR RKJL); the Department of Nutrition Harvard School of Public Health Boston MA (KN);the Institute of Epidemiology Helmholtz Zentrum München Neuherberg Germany (JL).
2. Supported by ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety" (contract no 513943).
3. Address correspondence to J Linseisen, Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstr. 1, D-85746 Neuherberg, Germany. E-mail: j.linseisen@helmholtz-muenchen.de .
 

About MenaQ7®

MenaQ7, the Natural Vitamin K2 is extracted from fermented soybeans with guaranteed actives and stability, clinical substantiation and patents granted and pending. MenaQ7 provides the Natural K2 Vitamin in a form of menaquinone-7, the long chained molecule offering superior bioavailability and health effects in low doses, which has been tied to both bone and cardiovascular health – www.menaq7.com
 

About NattoPharma

NattoPharma, Norway, is the exclusive international supplier and brand-owner of MenaQ7, the most effective natural form of vitamin K2. Vitamin K2 (MK-7) was recently amended by the EU commission to the list of legally added vitamins for fortified food and food supplements. NattoPharma ASA is listed on the Oslo Axess list at the Oslo Stock Exchange. The company has established an extensive research and development program aimed at documenting the benefits of vitamin K2. Please see further information on  www.nattopharma.com  
 

Further Information:

CEO Morten Sundstø Tel: +47 950 61860

---

Government Grant for Not Rearing Pigs

Rt Hon David Milliband, MP
Secretary of State,
Department for Environment, Food and Rural Affairs (DEFRA),
Nobel House, 17 Smith Square
London SW1P 3JR

Dear Secretary of State,

My friend, who is in farming at the moment, recently received a cheque for £3,000 from the Rural Payments Agency for not rearing pigs.. I would now like to join the 'not rearing pigs' business.

In your opinion, what is the best kind of farm not to rear pigs on, and which is the best breed of pigs not to rear? I want to be sure I approach this endeavour in keeping with all government policies, as dictated by the EU under the Common Agricultural Policy.

I would prefer not to rear bacon pigs, but if this is not the type you want not rearing, I will just as gladly not rear porkers. Are there any advantages in not rearing rare breeds such as Saddlebacks or Gloucester Old Spots, or are there too many people already not rearing these?

As I see it, the hardest pan of this programme will be keeping an accurate record of how many pigs I haven't reared. Are there any Government or Local Authority courses on this?

My friend is very satisfied with this business. He has been rearing pigs for forty years or so, and the best he ever made on them was £1,422 in 1968. That is – until this year, when he received a cheque for not rearing any.

If I get £3,000 for not rearing 50 pigs, will I get £6,000 for not rearing 100?  I plan to operate on a small scale at first, holding myself down to about 4,000 pigs not raised, which will mean about £240,000 for the first year. As I become more expert in not rearing pigs, I plan to be more ambitious, perhaps increasing to, say, 40,000 pigs not reared in my second year, for which I should expect about £2.4 million from your department. Incidentally, I wonder if I would be eligible to receive tradable carbon credits for all these pigs not producing harmful and polluting methane gases?

Another point: These pigs that I plan not to rear will not eat 2,000 tonnes of cereals. I understand that you also pay farmers for not growing crops. Will I qualify for payments for not growing cereals to not feed the pigs I don't rear?

I am also considering the 'not milking cows' business, so please send any information you have on that too. Please could you also include the current Defra advice on set aside fields? Can this be done on an e-commerce basis with virtual fields (of which I seem to have several thousand hectares)?

In view of the above you will realize that I will be totally unemployed, and will therefore qualify for unemployment benefits.  I shall of course be voting for your party at the next general election.

Yours faithfully,
 
Nigel Johnson-Hill
Sustainabilitynt@aol.com
Parkfarm, Milland,
Liphook GU30 7JT

---